重大公告
New Appointment of Compensation Committee Member
Date of occurrence of the change: Sep 28, 2020 Name of the functional committees: Compensation committee Name and resume of the previous position holder: Chung-Ming …
TFDA clearance for Phase 1 clinical study for active immunotherapeutic cancer vaccine, OBI-866
1.Date of occurrence of the event: Aug 25, 2020 2.Company name: OBI Pharma Inc. 3.Relationship to the Company (please enter “head office” or “subsidiaries”): Head …
TFDA clearance for Phase 1 clinical study for Novel Botulinum Toxin, OBI-858
1.Date of occurrence of the event: Aug 25, 2020 2.Company name: OBI Pharma Inc. 3.Relationship to the Company (please enter “head office” or “subsidiaries”): Head …
Announcement on the change of representative of corporate director
1.Date of occurrence of the change: Aug 03, 2020 2.Name of legal person: Sheng Chen Investment Co. Ltd 3.Name and resume of the previous position …
Announcement on resignation of Audit Committee Member
1.Date of occurrence of the change: Jul 31, 2020 2.Name of the functional committees: Audit Committee 3.Name and resume of the previous position holder: Chung-Ming …